Amplifybio LLC

Amplifybio LLC is a for-profit corporate entity registered in SAM.gov, located in Galloway, Ohio, that specializes in providing advanced biomedical research and testing services to federal agencies. The company offers comprehensive scientific support primarily in toxicological evaluations, non-clinical studies, veterinary assistance, and medical research across various specialized domains. While specific details about the company's full background are limited in this dataset, the federal award history indicates a robust capability in conducting complex scientific research and support services for government research initiatives.

The federal contract sub-awards reveal that Amplifybio LLC has extensively worked with Battelle Memorial Institute as a primary subcontractor, performing a wide range of specialized scientific services. These services include toxicological evaluations for various divisions, protocol development, non-clinical studies, toxicology studies, veterinary consultation, pathology analysis, and research on medical countermeasures. Their contract work spans diverse research areas such as screening potential medical countermeasures to chlorine gas, immunogenicity testing of vaccine candidates, studies on non-human primate models of filovirus infection, and pharmacokinetic analyses. The contract awards suggest they work closely with federal agencies like NIAID (National Institute of Allergy and Infectious Diseases) and NCATS (National Center for Advancing Translational Sciences), providing critical scientific research and evaluation services.

In terms of federal grant sub-awards, Amplifybio LLC has at least one recorded grant sub-award with The Children's Hospital of Philadelphia, focused on conducting a specialized toxicity and biodistribution study. The specific grant involves a 2-week intravenous infusion toxicity study on a specific medical research subject (LNP.CPS1.Q335X) using cynomolgus monkeys under Good Laboratory Practice (GLP) standards. This grant sub-award demonstrates the company's capability to perform highly specialized, precise scientific research studies that require extensive laboratory expertise, animal handling, and rigorous scientific protocols. The grant work appears to be centered on advanced medical research, potentially in areas of genetic or pharmaceutical research, though the full scope of the study is not completely detailed in the available information.